
    
      The aim of this study is to examine the efficacy and toxicity of focal salvage high dose rate
      brachytherapy (HDR BT) for patients with locally recurrent prostate cancer after definitive
      external beam radiotherapy. Furthermore, the investigators want to assess, whether it is
      feasible to perform salvage HDR BT as a focal treatment based on multiparametric (mp) pelvine
      MRI and PSMA PET/CT.
    
  